When to Order Free T3 (Triiodothyronine)
Free T3 measurement should be reserved for patients with suppressed TSH (<0.01 mIU/L) and normal or low free T4 when T3 thyrotoxicosis is suspected—it has no role in monitoring hypothyroidism or routine thyroid screening.
Primary Indication: Suspected T3 Thyrotoxicosis
Order free T3 only when ALL of the following criteria are met:
- TSH is markedly suppressed (ideally <0.01 mIU/L, at minimum <0.1 mIU/L) 1, 2
- Free T4 is normal or decreased 1, 3
- Patient has clinical symptoms of hyperthyroidism (palpitations, weight loss, tremor, heat intolerance) 2
- You are evaluating for primary hyperthyroidism, not monitoring treated disease 3
The likelihood of detecting T3 thyrotoxicosis increases dramatically with lower TSH cutoffs: only 10.3% at TSH <0.3 μIU/mL versus 27.6% at TSH <0.01 μIU/mL 1. In newly diagnosed hyperthyroidism, all patients with T3 thyrotoxicosis had TSH <0.01 μIU/mL 1.
Clinical Context Where Free T3 May Be Useful
Outpatient Setting (Preferred)
- T3 thyrotoxicosis is detected in 34% of outpatients with TSH <0.01 μIU/mL and normal/low free T4, compared to only 14% in hospitalized patients 1
- The higher yield in outpatients reflects the confounding effects of non-thyroidal illness on inpatient thyroid testing 1
Specific Clinical Scenarios
- Evaluating relapse in previously treated hyperthyroidism: Patients cured from thyrotoxicosis but suspected of relapse may present with isolated T3 elevation 4
- Assessing amiodarone-induced thyrotoxicosis: Free T3 helps distinguish type 1 (hyperthyroid) from type 2 (thyroiditis) amiodarone toxicity 3
- Predicting outcome of antithyroid drug therapy in Graves' disease: Persistently elevated T3 may predict treatment failure 3
- Evaluating nodular thyroid disease: Patients with multinodular goiter or solitary nodules on exam who have suppressed TSH and normal free T4 should have free T3 measured to detect autonomous T3 production 2
When NOT to Order Free T3
Monitoring Hypothyroidism (Most Common Inappropriate Use)
Never order free T3 to assess levothyroxine dosing in hypothyroid patients. 5 This is explicitly discouraged by the Endocrine Society's Choosing Wisely campaign 5. TSH and free T4 are sufficient for monitoring thyroid hormone replacement 5. Implementation of electronic alerts to prevent this inappropriate ordering reduced unnecessary T3 testing by >44% 5.
Diagnosing Hypothyroidism
Free T3 has no role in diagnosing hypothyroidism 3. TSH is the single most sensitive screening test with 98% sensitivity and 92% specificity 6. If TSH is elevated, measure free T4 to distinguish subclinical from overt hypothyroidism—free T3 adds nothing 7, 6.
Routine Thyroid Screening
Do not order free T3 as part of initial thyroid function assessment 6. Start with TSH; if abnormal, add free T4 6. Free T3 is only added in the specific scenario of suppressed TSH with normal/low free T4 described above 1, 3.
Practical Algorithm for Free T3 Ordering
Measure TSH first in all patients with suspected thyroid dysfunction 6
If TSH is suppressed (<0.1 mIU/L):
- Measure free T4 6
- If free T4 is elevated → overt hyperthyroidism; free T3 not needed
- If free T4 is normal or low → proceed to step 3
If TSH <0.01 mIU/L AND free T4 normal/low:
If free T3 is elevated:
Evidence Quality and Prevalence
T3 thyrotoxicosis is rare, occurring in only 0.5% of patients undergoing thyroid testing 1. Among 4,366 patients who had TSH, free T4, and free T3 measured simultaneously, only 70 (1.6%) had biochemical T3 thyrotoxicosis, and only 20 (0.5%) represented newly diagnosed hyperthyroidism 1. The vast majority of free T3 tests ordered provide no clinically useful information 1, 5.
Common Pitfalls
- Ordering free T3 reflexively with TSH and free T4: This wastes resources; free T3 should only be added when specific criteria are met 1, 5
- Using free T3 to monitor levothyroxine therapy: This is the most common inappropriate use and should be actively discouraged 5
- Ordering free T3 when TSH is only mildly suppressed (0.1-0.4 mIU/L): The yield is too low; wait until TSH is <0.01 mIU/L 1
- Testing hospitalized patients: Non-thyroidal illness dramatically reduces the diagnostic yield of free T3 testing 1